Cargando…
Alport syndrome: facts and opinions
In this commentary, I review recent advances in Alport syndrome genetics, diagnostics, and therapeutics. I also offer some opinions regarding strategies to optimize the early identification of affected individuals to promote early therapeutic intervention.
Autor principal: | Kashtan, Clifford |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247785/ https://www.ncbi.nlm.nih.gov/pubmed/28163907 http://dx.doi.org/10.12688/f1000research.9636.1 |
Ejemplares similares
-
Multidisciplinary Management of Alport Syndrome: Current Perspectives
por: Kashtan, Clifford
Publicado: (2021) -
Renal transplantation in patients with Alport syndrome: patient selection, outcomes, and donor evaluation
por: Kashtan, Clifford E
Publicado: (2018) -
Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative
por: Kashtan, Clifford E., et al.
Publicado: (2012) -
Urinary Monocyte Chemoattractant Protein-1 in Patients With Alport Syndrome
por: Kashtan, Clifford, et al.
Publicado: (2022) -
Somatic Mosaicism in a Male Patient With X-linked Alport Syndrome
por: Bu, Lihong, et al.
Publicado: (2019)